Invivyd (IVVD) EPS (Diluted) (2021 - 2025)

Invivyd (IVVD) EPS (Diluted) (2021 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Diluted) (Qtr)
1 Oculis Holding AG 66,921.77 Bn 66,921.49 Bn - 0.00
2 Nanobiotix 1,933.35 Bn 1,933.29 Bn - -
3 Akari Therapeutics 1,063.56 Bn 1,063.56 Bn - 0.00
4 BeOne Medicines 468.54 Bn 463.75 Bn 1.35 Bn 0.15
5 Vertex Pharmaceuticals 123.45 Bn 116.20 Bn 2.59 Bn 4.02
6 Regeneron Pharmaceuticals 70.42 Bn 61.67 Bn 3.31 Bn 6.75
7 Belite Bio 63.57 Bn 63.57 Bn - 0.00
8 Argenx Se 55.83 Bn 50.65 Bn 1.41 Bn 7.33
9 Alnylam Pharmaceuticals 37.75 Bn 34.74 Bn 959.66 Mn 1.49
10 Invivyd 106.01 Mn -120.67 Mn 16.07 Mn -0.07

Historic Data

Download Data
DateValue
Dec 31, 2025 -0.07
Sep 30, 2025 -0.07
Jun 30, 2025 -0.13
Mar 31, 2025 -0.14
Dec 31, 2024 -0.16
Sep 30, 2024 -0.53
Jun 30, 2024 -0.42
Mar 31, 2024 -0.69
Dec 31, 2023 -0.70
Sep 30, 2023 -0.41
Jun 30, 2023 -0.50
Mar 31, 2023 -0.37
Dec 31, 2022 -0.45
Sep 30, 2022 -0.49
Jun 30, 2022 -0.54
Mar 31, 2022 -1.03
Dec 31, 2021 -1.95
Sep 30, 2021 -0.98
Jun 30, 2021 -178.86